Product Information
TOSYMRA 10 MG NASAL SPRAY is a brand product labeled by Tonix Medicines, Inc., priced at $108.2212 per EA under NDC 70792081261. Its NADAC has been published 54 times since Aug 13, 2025.
FDA first approved this application on Jan 25, 2019.
The High Outlier badge above means this manufacturer's average price in the Sumatriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/.1mL
Manufacturer
Tonix Medicines, Inc.NDC
70792081261
Classification
Brand
Dosage Form
SPRAY
Route
NASAL
Effective Date
8/19/2026
Active Ingredients
SUMATRIPTANApproval Type
New Drug (NDA)
FDA Application
NDA210884FDA Approved
1/25/2019
On Market Since
7/1/2023
Pharmacological Classes
Price Statistics
The NADAC for TOSYMRA 10 MG NASAL SPRAY has been published 54 times since Aug 13, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $108.2212 per EA |
|---|---|
| All-time high | $108.3932 (Dec 10, 2025) |
| All-time low | $107.6342 (Dec 17, 2025) |
| 52-week high | $108.3932 |
| 52-week low | $107.6342 |
| Median price | $108.1796 |
| Average price | $108.1203 |
| Largest weekly change | -0.7% (Dec 17, 2025) |
| Weeks tracked | 54 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sumatriptan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOSYMRA 10 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for TOSYMRA 10 MG NASAL SPRAY, manufactured by Tonix Medicines, Inc., is $108.2212 per EA (NDC 70792081261), effective Aug 19, 2026.
How has the price of TOSYMRA 10 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for TOSYMRA 10 MG NASAL SPRAY has held within roughly two percent of its current level. It has been tracked across 54 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for TOSYMRA 10 MG NASAL SPRAY?
Since Aug 13, 2025, the NADAC for TOSYMRA 10 MG NASAL SPRAY has ranged from a low of $107.6342 (Dec 17, 2025) to a high of $108.3932 (Dec 10, 2025), with a median of $108.1796 per EA.
Are there cheaper alternatives to TOSYMRA 10 MG NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of TOSYMRA 10 MG NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TOSYMRA 10 MG NASAL SPRAY?
TOSYMRA 10 MG NASAL SPRAY (NDC 70792081261) is labeled by Tonix Medicines, Inc., and CMS classifies it as a brand product.